Mexico Veterinary Ocular Antivirals Market Size, by Product Classification (2024-2032)

Growing preference for effective antiviral formulations strengthened the position of branded veterinary products within Mexico’s ocular therapeutics landscape. In ***, this segment was valued at USD ***.*** thousand, the highest among all categories, while off-label human drugs remained the lowest at USD *** thousand. The trend continues through ***, where branded formulations are estimated at USD ***.*** thousand, maintaining their lead over generic and compounded drugs. The dominance of branded antivirals reflects superior clinical reliability, veterinarian trust, and consistent quality compliance driving stronger adoption. Throughout the forecast period, the Mexico Veterinary Ocular Antivirals Market is projected to remain led by branded veterinary products , reaching USD ***.*** thousand by ***, while off-label human use is projected to record the lowest share at USD *** thousand. This sustained leadership is attributed to increased innovation in ophthalmic formulations, improve...